V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20204887 | 20127273 | 1.72 | 80 | Palliative (P) | 2018-03-14 | 2018-03-26 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101034762 |
| 20204897 | 20127274 | 1.72 | 62.95 | Palliative (P) | 2017-12-22 | 2018-01-12 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101448506 |
| 20204899 | 20127275 | 1.61 | 68.2 | Neo-adjuvant (N) | 2016-08-12 | 2016-09-06 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CAPECITABINE + CARBOPLATIN | 100027348 |
| 20204901 | 20127276 | 1.8 | 124 | Palliative (P) | 2016-07-06 | 2016-07-06 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101439217 |
| 20204917 | 20127277 | 1.65 | 72.1 | null | 2016-05-15 | 2016-06-07 | Capecitabine + Carboplatin + RT | 02 | null | CAPECITABINE + CARBOPLATIN | 100125248 |
| 20204920 | 20127278 | null | 70 | null | 2021-05-29 | 2021-06-02 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | CAPECITABINE + CARBOPLATIN | 101369066 |
| 20204922 | 20127279 | 1.63 | 124.9 | null | 2016-12-10 | 2016-12-24 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101816100 |
| 20204929 | 20127280 | 1.68 | 95.1 | Palliative (P) | 2019-02-14 | 2019-02-15 | ECX | N | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101635049 |
| 20204938 | 20127281 | 1.89 | 64 | null | 2020-11-24 | 2020-12-15 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 101341226 |
| 20204939 | 20127282 | 1.5 | 83.3 | Palliative (P) | 2018-03-04 | 2018-04-15 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100603729 |
| 20204941 | 20127283 | 1.55 | 74 | null | 2017-06-20 | 2018-01-04 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101770339 |
| 20204943 | 20127284 | 1.7 | 48.8 | null | 2016-08-19 | 2016-11-26 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100012538 |
| 20204944 | 20127285 | 1.63 | 87.65 | Palliative (P) | 2016-07-15 | 2016-09-03 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100879931 |
| 20204954 | 20127286 | 1.61 | 82.7 | Adjuvant (A) | 2019-08-10 | 2019-08-20 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100621452 |
| 20204956 | 20127287 | 1.56 | 52.75 | Neo-adjuvant (N) | 2019-06-20 | 2019-07-11 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100860186 |
| 20204957 | 20127288 | 1.79 | 131 | Neo-adjuvant (N) | 2018-01-28 | 2018-02-26 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100900560 |
| 20204970 | 20127289 | 1.68 | 82 | Curative (C) | 2017-04-07 | 2018-04-08 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101092036 |
| 20204991 | 20127290 | 1.64 | 56.7 | Palliative (P) | 2019-01-23 | 2019-02-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100259127 |
| 20205002 | 20127291 | 1.88 | 58.4 | Adjuvant (A) | 2018-07-12 | 2018-07-28 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101648355 |
| 20205010 | 20127292 | 1.8 | 49.8 | null | 2016-07-07 | 2016-07-07 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101245632 |
| 20205014 | 20127293 | 1.8 | 96.8 | Palliative (P) | 2016-11-28 | 2016-12-05 | Cape+Cisplatin+Trastuzumab Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100219317 |
| 20205016 | 20127294 | 1.55 | 75 | Palliative (P) | 2017-06-30 | 2017-07-15 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100705929 |
| 20205018 | 20127295 | 1.62 | 84.43 | null | 2019-06-30 | 2019-07-10 | Cape+Cisplatin+Trastuzumab Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101109119 |
| 20205019 | 20127296 | 1.74 | 56 | Palliative (P) | 2017-12-24 | 2018-01-07 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101515766 |
| 20205029 | 20127297 | 1.8 | 51.7 | Palliative (P) | 2016-12-16 | 2017-04-28 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101470868 |
| 20205034 | 20127298 | 1.84 | 87.3 | Neo-adjuvant (N) | 2016-03-26 | 2016-04-18 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100777010 |
| 20205036 | 20127299 | 1.83 | 69 | Palliative (P) | 2017-11-08 | 2018-02-25 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100685280 |
| 20205039 | 20127300 | 1.74 | 57 | null | 2019-03-03 | 2019-03-26 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100092981 |
| 20205054 | 20127301 | 1.53 | 68 | Neo-adjuvant (N) | 2020-07-19 | 2020-08-16 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100905075 |
| 20205067 | 20127302 | 1.7 | 50.5 | Neo-adjuvant (N) | 2018-05-18 | 2018-05-30 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100185038 |
| 20205070 | 20127303 | 1.76 | 49.4 | Palliative (P) | 2017-10-10 | 2017-10-10 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100911532 |
| 20205071 | 20127304 | 1.63 | 76 | null | 2022-04-11 | 2022-04-29 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100630500 |
| 20205080 | 20127305 | 1.77 | 48.1 | null | 2015-05-11 | 2016-05-20 | HCX (Cape + Cisp + Tras) - Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100850927 |
| 20205081 | 20127306 | null | 59.2 | Curative (C) | 2018-03-01 | 2018-03-27 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100167320 |
| 20205087 | 20127307 | 1.66 | 38.9 | Palliative (P) | 2020-05-15 | 2020-06-02 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CARBOPLATIN | 101754139 |
| 20205092 | 20127308 | 1.84 | 74.9 | Palliative (P) | 2021-08-28 | 2021-09-19 | GEMCITABINE + NAB PACLITAXEL | 02 | Y | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100291238 |
| 20205094 | 20127309 | 1.82 | 76.2 | Neo-adjuvant (N) | 2016-07-08 | 2016-11-19 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100917621 |
| 20205103 | 20127310 | 1.55 | 40.15 | Adjuvant (A) | 2019-06-22 | 2019-07-13 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101705121 |
| 20205104 | 20127311 | 1.71 | 71.3 | null | 2017-11-05 | 2017-11-12 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100936904 |
| 20205109 | 20127312 | 1.7 | 50 | null | 2019-06-29 | 2019-07-22 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101378191 |
| 20205112 | 20127313 | 1.7 | 56 | Palliative (P) | 2017-08-28 | 2018-01-19 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101827890 |
| 20205113 | 20127314 | null | 78.8 | null | 2018-11-07 | 2018-11-07 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100153699 |
| 20205115 | 20127315 | 1.52 | 85 | Neo-adjuvant (N) | 2018-03-25 | 2018-05-23 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101497520 |
| 20205117 | 20127316 | null | 78.8 | Palliative (P) | 2016-03-24 | 2016-07-19 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100430179 |
| 20205120 | 20127317 | 1.65 | 42 | Adjuvant (A) | 2018-05-24 | 2018-06-02 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101016806 |
| 20205122 | 20127318 | 1.8 | 65.2 | Palliative (P) | null | 2020-02-02 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101116712 |
| 20205126 | 20127319 | 1.56 | 91.4 | Adjuvant (A) | 2019-07-04 | 2019-07-26 | GEMCITABINE + NAB PACLITAXEL | 02 | y | GEMCITABINE + NAB-PACLITAXEL | 100224569 |
| 20205129 | 20127320 | 1.88 | 75 | Palliative (P) | 2019-09-05 | 2019-11-15 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101336397 |
| 20205135 | 20127321 | 1.68 | 74.2 | Palliative (P) | 2017-06-11 | 2017-12-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100227039 |
| 20205139 | 20127322 | 1.64 | 37 | Palliative (P) | 2017-03-19 | 2017-04-09 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100928704 |